ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,679 | +30.4% | 55,893 | +62.5% | 0.00% | – |
| Q2 2023 | $128,619 | +106.6% | 34,390 | +80.7% | 0.00% | – |
| Q1 2023 | $62,241 | -25.5% | 19,034 | +9.6% | 0.00% | – |
| Q4 2022 | $83,516 | -6.2% | 17,363 | +11.3% | 0.00% | – |
| Q3 2022 | $89,000 | -1.1% | 15,607 | +23.4% | 0.00% | – |
| Q2 2022 | $90,000 | -62.8% | 12,644 | -62.3% | 0.00% | – |
| Q1 2022 | $242,000 | -54.1% | 33,514 | -43.1% | 0.00% | – |
| Q4 2021 | $527,000 | -77.9% | 58,927 | -13.5% | 0.00% | -100.0% |
| Q3 2021 | $2,389,000 | – | 68,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |